Rocío García-Becerra Selected Research

seocalcitol

3/2024	EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.
1/2017	The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rocío García-Becerra Research Topics

Disease

33	Neoplasms (Cancer) 03/2024 - 09/2006
22	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2006
6	Carcinogenesis 01/2022 - 02/2010
5	Triple Negative Breast Neoplasms 09/2023 - 01/2019
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2023 - 07/2010
2	Papillomavirus Infections 01/2022 - 04/2009
2	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2020
2	Body Weight (Weight, Body) 10/2017 - 10/2014
1	Endometrial Neoplasms (Endometrial Cancer) 11/2023
1	Squamous Intraepithelial Lesions 05/2023
1	Medulloblastoma 01/2022
1	Hypoxia (Hypoxemia) 12/2021
1	Infections 01/2019
1	Premature Birth (Birth, Premature) 01/2019
1	Carcinoma (Carcinomatosis) 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 05/2013
1	Disease Progression 12/2012
1	Azoospermia 02/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Lymphoma (Lymphomas) 08/2011

Drug/Important Bio-Agent (IBA)

20	Calcitriol (Calcijex)FDA LinkGeneric 03/2024 - 02/2010
7	Antineoplastic Agents (Antineoplastics)IBA 07/2022 - 02/2010
6	Estrogen ReceptorsIBA 03/2024 - 12/2012
6	Vitamin D FDA LinkGeneric 05/2023 - 10/2014
6	Potassium Channels (Potassium Channel)IBA 01/2019 - 04/2009
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2015
5	RadiopharmaceuticalsIBA 04/2014 - 06/2009
4	Lapatinib (GW572016)FDA Link 03/2024 - 01/2015
4	Estrogen Receptor Modulators (Antiestrogen)IBA 03/2024 - 04/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2010
4	Hormones (Hormone)IBA 01/2021 - 02/2010
4	IntegrinsIBA 11/2019 - 05/2011
4	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2015 - 07/2010
3	PhytochemicalsIBA 11/2023 - 11/2019
3	CytokinesIBA 02/2023 - 12/2017
3	EnzymesIBA 01/2021 - 09/2006
3	Testosterone (Sustanon)FDA Link 01/2019 - 09/2006
3	AstemizoleIBA 01/2019 - 01/2012
3	Gefitinib (Iressa)FDA Link 01/2019 - 01/2015
3	EDDA (NiEDDA)IBA 04/2014 - 06/2009
2	seocalcitolIBA 03/2024 - 01/2017
2	Tamoxifen FDA LinkGeneric 11/2023 - 12/2012
2	mangostinIBA 11/2023 - 02/2023
2	CurcuminIBA 07/2022 - 11/2019
2	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2012
2	Histone Deacetylases (Histone Deacetylase)IBA 12/2021 - 11/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 10/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2011
2	Type I Tumor Necrosis Factor ReceptorsIBA 01/2019 - 12/2017
2	CathelicidinsIBA 10/2017 - 11/2016
2	Vitamin D3 24-HydroxylaseIBA 10/2017 - 01/2012
2	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 10/2017 - 07/2010
2	neratinibIBA 01/2017 - 01/2015
2	Peptides (Polypeptides)IBA 11/2016 - 05/2013
2	Bombesin Receptors (Bombesin Receptor)IBA 04/2011 - 06/2009
2	Ether (Diethyl Ether)IBA 07/2010 - 02/2010
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2009 - 09/2006
1	afimoxifene (hydroxytamoxifen)IBA 11/2023
1	AZD4547IBA 09/2023
1	PlasticsIBA 09/2023
1	CalciumIBA 05/2023
1	Protein Kinase CIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	Estrogen Receptor betaIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 12/2021
1	pyridineIBA 12/2021
1	Cholecalciferol (Vitamin D3)FDA Link 11/2021
1	AcidsIBA 11/2021
1	cyclo(arginylglycyl)IBA 11/2021
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 11/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	ResveratrolIBA 11/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 12/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017
1	Calcifediol (Calcidiol)FDA Link 10/2017
1	Mixed Function Oxygenases (Monooxygenases)IBA 10/2017
1	Ethanol (Ethyl Alcohol)IBA 10/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2017
1	SteroidsIBA 05/2016
1	Oxygen (Dioxygen)IBA 01/2015
1	SolutionsIBA 01/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	OzoneIBA 01/2015
1	Thrombospondin 1IBA 10/2014
1	Aromatase InhibitorsIBA 12/2012
1	Progesterone CongenersIBA 02/2012
1	CytochromesIBA 01/2012
1	Cytochrome P-450 CYP3AIBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	PhytohemagglutininsIBA 08/2011
1	GoldIBA 05/2011

Therapy/Procedure

16	Therapeutics 11/2023 - 04/2009
3	Drug Therapy (Chemotherapy) 11/2021 - 12/2012
2	Radiotherapy 12/2017 - 04/2011
1	Drug Tapering 11/2023
1	Intraperitoneal Injections 10/2014